Stress, Inflammation and Neuroimaging in Major Depressive Disorder as Compared to Premenstrual Dysphoric Disorder

ConditionsMDDPMDD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorUniversity Hospital Tuebingen

About this trial

Premenstrual dysphoric disorder (PMDD) is a sex-specific depressive disorder where depressive symptom severity drastically changes in relation to menstrual cycle phase. It is characterized by late luteal phase symptoms of affective lability, irritability, depressed mood, and anxiety. A lot remains unclear and further studies are needed in order to improve the understanding of PMDD and to differentiate it from major depressive disorder (MDD). To date, and in contrast to MDD, the neural correlates of PMDD have been sparsely and poorly investigated. The aim of this study is therefore to investigate the neural correlates of PMDD as compared to MDD and to relate them to stress reactivity. Therefore, three groups of naturally cycling women will be investigated and compared, namely (1) women with MDD, (2) women with PMDD, and (3) healthy control women.

Stress and HPA axis activity are assumed to play a crucial role in the development of many mental disorders, including MDD. How stress reactivity and HPA axis activity are connected to PMDD still needs to be investigated. Furthermore, the HPA axis can affect or suppress the activity of the hypothalamic-pituitary-gonadal (HPG) axis, which is involved mainly in the reproductive, but also the immune system, making it an important candidate for the investigation of sex-specific differences in stress reactivity.

There are sex-specific differences in stress reactivity, but also in the prevalence of stress-related diseases. Women are twice as likely to suffer from depression than men and the first onset of MDD usually peaks during the reproductive years. As to why these differences exist, a recent theory suggests that ovarian hormone fluctuations function as modulators of women's susceptibility to stress and that altered reactivity to stressors during different cycle phases plays a role in the etiology of depressive disorders. This hypothesis extends the Social Signal Transduction Theory of Depression which first and foremost relates depression to inflammation. They postulate a critical role of cytokines for understanding the pathogenesis of depression. Therefore, ovarian hormone fluctuations, but also inflammation in regard to MDD and PMDD and stress reactivity will be investigated in this study.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Women,

age between 18 and 40 years (no menopausal women),

regular menstrual cycles (25-31 days),

normal body mass index (18-35 kg/m2),

Disqualifiers

any neurological or mental disease (only for healthy participants)

hormonal, metabolic or chronical diseases

pregnancy

women who gave birth or were breastfeeding within the last year

Trial population

Participants will be recruited by newspaper/social media advertisements, e-mails ("Rundmail") and posting notices ("Aushänge") at different places at the University Hospital Tübingen as well as the University of Tübingen and in social networks.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

75 Participants
are grouped into 3 trial groups
Group A: major depressive disorder group
Group B: premenstrual dysphoric disorder group
Group C: healthy controls

Trial outcomes

Primary outcomes

1

neural stress reactivity / activation of the CCN (cognitive control network) during stress-related tasks

activity in stress-circuits of the brain, especially DLPFC activity

Time frame
during the MIST (20 minutes)
2

stress-related cortisol reactivity

cortisol level change in saliva between before and after the MIST

Time frame
five cortisol measurements at MRI arrival, before the MIST, 50 minutes after the MIST, 70 minutes after the MIST, 120 minutes after the MIST
3

TNF-alpha in response to stress-related task

TNF-alpha in blood before / after the MIST

Time frame
blood sample before and after the MIST (approx. 120 minutes)
4

CRP in response to stress-related task

CRP in blood before / after the MIST

Time frame
blood sample before and after the MIST (approx. 120 minutes)

Secondary outcomes

1

different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls

ANOVA for different levels of CRP in different groups (PMDD, MDD, control)

Time frame
Baseline (T1)
2

different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls

ANOVA for different levels of IL-6 in different groups (PMDD, MDD, control)

Time frame
Baseline (T1)
3

different levels of inflammation in Major Depressive Disorder, Premenstrual Dysphoric Disorder and Healthy Controls

ANOVA for different levels of TNF-alpha in different groups (PMDD, MDD, control)

Time frame
Baseline (T1)
4

changes in stress-reactivity induced by varying levels of sex hormones

ANOVA for cortisol reactivity between different cycle phases (luteal phase, follicular phase)

Time frame
MIST at T1 (follicular) and T2 (luteal phase) (2 weeks)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.